Last reviewed · How we verify
NCT02310503: REGESMOHS
Spanish Registry of Mohs Surgery
trial testing Mohs surgery in Skin Neoplasms in 6,000 participants. Completed in 29 February 2020.
29 February 2020
Quick facts
| Lead sponsor | Fundación Academia Española de Dermatología |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 6,000 |
| Start date | 1 July 2013 |
| Primary completion | 29 February 2020 |
| Estimated completion | 29 February 2020 |
| Sites | 15 locations across Spain |
Drugs / interventions tested
- Mohs surgery
Conditions studied
- Skin Neoplasms — all drugs for Skin Neoplasms →
- Carcinoma, Basal Cell — all drugs for Carcinoma, Basal Cell →
- Carcinoma, Squamous Cell — all drugs for Carcinoma, Squamous Cell →
- Dermatofibrosarcoma — all drugs for Dermatofibrosarcoma →
Sponsor
Fundación Academia Española de Dermatología
Who can join
18 and older, female only, with Skin Neoplasms or Carcinoma, Basal Cell. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
REGESMOHS (Registro Español de cirugía de Mohs) aims at describing effectiveness of Mohs surgery, and patient, tumor and technique factors related to adverse events and tumor recurrence. REGESMOHS is a prospective cohort, including all patients considered for Mohs surgery in participating centers. All consecutive patients are included. The only exclusion criteria are being under 18-years-old or legally incompetent. Pre-planned follow-up is as required by common clinical practice, but at least once a year for the study period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02310503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Neoplasms
Currently open trials in the same condition.
- NCT07415291 — CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis · active not recruiting
- NCT04267861 — M7824 Related Adverse Effects in Adults With Cancer · active not recruiting
Other Fundación Academia Española de Dermatología trials
Trials by the same sponsor.
- NCT05673681 — Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry · recruiting
- NCT05674695 — Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy · recruiting
- NCT03646422 — AEDV Registry of Primary Cutaneous Lymphoma · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02310503 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Academia Española de Dermatología
- Last refreshed: 5 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02310503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing